Disease-Modifying MS Therapies Market Forecast Highlights India at 8.4% CAGR
The disease-modifying multiple sclerosis therapies market is projected to grow at a 6.4% CAGR through 2036, supported by early high-efficacy treatment adoption, expanding therapeutic options for progressive MS, and advances in long-term disease management. October 29, 2026 — The global disease-modifying multiple sclerosis therapies market is projected to increase from USD 30.32 billion in...
0 Comments 0 Shares 65 Views 0 Reviews
Uddokta 64 https://uddokta64.com